| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.9 |